Skip to main content
Home ESG Stocks
Evolent Health, Inc. (EVH) Stock Analysis & ESG Ratings
EVH

Evolent Health, Inc.

Market overview

USD 4.28

Down−USD 0.22 (−4.89%) Day change

Open
USD 4.45
Previous close
USD 4.50
Day high
USD 4.51
Day low
USD 4.22
Volume
2,647,227
Market cap
USD 483,893,984

USD · Market data via Massive Stock Widgets · Last close · As of

Price chart · 1 Year
Evolent Health, Inc. 1 Year price chartEvolent Health, Inc., nyse:EVH, 1 Year price chart in USD. Start USD 9.61, end USD 4.28, high USD 9.99, low USD 2.17, down.
Period1 YearFirst closeUSD 9.61Last closeUSD 4.28Maximum closeUSD 9.99Minimum closeUSD 2.17Period change−USD 5.33Period percentage change−55.46%Chart as ofSep 1, 2026, 1:30 PM GMT+0000
View Chart Data
Representative chart points — 24 of 251
Date and time Open High Low Close Volume
USD 9.54 USD 9.76 USD 9.38 USD 9.61 1,755,400
USD 9.82 USD 10.08 USD 9.69 USD 9.99 1,941,300
USD 7.68 USD 7.74 USD 7.42 USD 7.53 1,531,600
USD 6.67 USD 6.84 USD 6.53 USD 6.67 3,190,500
USD 4.10 USD 4.13 USD 3.84 USD 3.87 7,893,400
USD 3.90 USD 4.03 USD 3.79 USD 3.91 6,001,100
USD 4.10 USD 4.10 USD 3.88 USD 3.97 3,913,600
USD 3.93 USD 4.03 USD 3.90 USD 4.02 2,517,900
USD 3.80 USD 3.91 USD 3.78 USD 3.84 1,919,100
USD 2.88 USD 2.94 USD 2.82 USD 2.85 2,872,200
USD 2.77 USD 2.77 USD 2.52 USD 2.56 5,127,600
USD 3.05 USD 3.10 USD 2.94 USD 3.07 3,110,200
USD 2.27 USD 2.34 USD 2.19 USD 2.27 4,530,500
USD 2.25 USD 2.26 USD 2.11 USD 2.17 2,822,100
USD 2.43 USD 2.43 USD 2.28 USD 2.33 3,565,000
USD 3.08 USD 3.61 USD 3.08 USD 3.47 2,861,800
USD 3.95 USD 4.32 USD 3.77 USD 4.16 3,433,300
USD 3.74 USD 3.98 USD 3.74 USD 3.90 2,260,500
USD 4.72 USD 4.91 USD 4.56 USD 4.80 2,109,700
USD 5.46 USD 5.53 USD 5.18 USD 5.42 2,564,800
USD 6.19 USD 6.21 USD 5.72 USD 5.87 2,962,900
USD 3.31 USD 3.31 USD 3.08 USD 3.18 4,141,600
USD 4.67 USD 4.74 USD 4.51 USD 4.68 2,298,900
USD 4.45 USD 4.51 USD 4.22 USD 4.28 2,647,227

ESG & Sustainability Rating Breakdown

Synthesized multi-provider rating across Environmental, Social, and Corporate Governance dimensions.

Audited Methodology

Coverage PendingThird-Party ESG Coverage Under Review

Formal published scorecards from MSCI ESG Research and Sustainalytics are not currently available for this ticker. The Impact Investor tracks corporate sustainability disclosures, SEC 10-K filings, and governance releases.

Sustainability Strengths & Catalysts (Pros)

  • Scale in value-based care operations: Evolent manages clinical and administrative services for many health systems and payors, giving it operational scale and data assets to support population health management and care coordination.
  • Focus on improving outcomes for complex patients: The company’s care-management programs and clinical platforms are specifically designed to address high-cost, complex conditions, which can drive measurable quality improvements and reduced utilization whe
  • Partnership model with health systems and payors: Evolent’s contracting and joint-venture arrangements align financial incentives with clients around value-based payment models, which can support long-term sustainability of care improvements and shared ac

Material Risks & Governance Concerns (Cons)

  • Revenue exposure to policy and market shifts: A substantial portion of Evolent’s business depends on value-based reimbursement arrangements and government programs (Medicare/Medicaid); changes in reimbursement policy or plan participation can materially a
  • Operational and integration risks tied to large-scale contracts: Delivering complex care-management and IT services across multiple health systems carries execution, data governance and privacy risks, and failures in implementation or data security incide

Company Profile & Business Model Overview

Financial & Valuation Fundamentals

Earnings Per Share (EPS)
$8.15
Dividend Yield
N/A

Data Integrity & Methodology Disclosure

Market quotes may be delayed and each visible snapshot states its source and observation time. ESG evaluations aggregate published ratings from MSCI ESG Research and Sustainalytics with normalized industry peer adjustments. Learn more in our ESG Rating Methodology.